The patented compound can be potentially applied in Huntington’s disease treatment – genetic central nervous system disease characterized by mobility issues and psychic disorders, among other symptoms. The Patent Office of the Republic of Poland granted another patent to the University of Gdańsk, for the invention titled ‘2 - izotiocyjanianoetylobenzen do…